Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | Director | March 20, 2018 | March 22, 2018 |
| TECOGEN INC.TGEN · Entity 6846 | Director | June 13, 2023 | June 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date March 20, 2018 · Filed March 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,811 |
Reported balance
After 2018-03-20 transaction · row 1
1 source rowRow 1 · 2018-03-20 · Exercise / conversion · Acquired 2,000 · Balance 14,811 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $6.36 · Expires 2023-07-11 | Direct | 1,333 |
Reported balance
After 2018-03-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-20 · Exercise / conversion · Acquired 2,000 · Balance 1,333 |
TECOGEN INC.
Report date June 13, 2023 · Filed June 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2033-06-13 | Direct | 175,000 |
Reported balance
After 2023-06-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-13 · Grant · Acquired 25,000 · Balance 175,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2023 Filed Jun 15, 2023 15:45 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $1.10 Strike: $1.10 | $27,500.00 |
DisclosureSEC source: 0001537435-23-000075 · wf-form4_168685829623815.xml · derivative · entry 1 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-13 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| June 23, 2022 Filed Jun 28, 2022 18:30 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $1.20 Strike: $1.20 | $30,000.00 |
DisclosureSEC source: 0001537435-22-000076 · wf-form4_165645543610149.xml · derivative · entry 1 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| July 09, 2020 Filed Jul 21, 2020 12:18 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.71 Strike: $0.71 | $71,000.00 |
DisclosureSEC source: 0001537435-20-000098 · wf-form4_159534831886004.xml · derivative · entry 1 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-09 F1 · derivative.exercise_date: 25% of options vest on each of the first four anniversaries of the grant date Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 17:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Options · Derivative | 2,000 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001144204-18-016458 · tv489137_form4.xml · derivative · entry 2 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,333 Underlying: Commom Stock · 2,000 shares Expires 2023-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 17:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-016458 · tv489137_form4.xml · nonDerivative · entry 1 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 18:08 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 2,000 | $0.00 Strike: $49.51 | $0.00 |
DisclosureSEC source: 0001144204-17-018961 · v463551_form4.xml · derivative · entry 2 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-03-30 F1 · security: The restricted stock and stock options vest on the first anniversary of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 18:08 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018961 · v463551_form4.xml · nonDerivative · entry 1 HOLUBOW FRED · CIK 0000905478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,811 F1 · security: The restricted stock and stock options vest on the first anniversary of the grant date. F2 · balance_after: The amount of common stock beneficially owned reported herein corrects a calculation error in the reporting person's prior filings. There are no unreported transactions by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.